- Home
- SUPN vs LION Comparison
SUPN vs LION Comparison
Compare SUPN & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- LION
- Stock Information
- Founded
- SUPN 2005
- LION 1997
- Country
- SUPN United States
- LION United States
- Employees
- SUPN N/A
- LION N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- LION Movies/Entertainment
- Sector
- SUPN Health Care
- LION Consumer Discretionary
- Exchange
- SUPN Nasdaq
- LION Nasdaq
- Market Cap
- SUPN 2.6B
- LION 1.9B
- IPO Year
- SUPN 2012
- LION N/A
- Fundamental
- Price
- SUPN $44.61
- LION $7.20
- Analyst Decision
- SUPN Buy
- LION Buy
- Analyst Count
- SUPN 2
- LION 9
- Target Price
- SUPN $43.00
- LION $8.88
- AVG Volume (30 Days)
- SUPN 631.6K
- LION 2.6M
- Earning Date
- SUPN 11-03-2025
- LION 11-06-2025
- Dividend Yield
- SUPN N/A
- LION N/A
- EPS Growth
- SUPN 1411.53
- LION N/A
- EPS
- SUPN 1.14
- LION N/A
- Revenue
- SUPN $665,125,000.00
- LION $3,986,900,000.00
- Revenue This Year
- SUPN $4.84
- LION N/A
- Revenue Next Year
- SUPN $17.69
- LION $16.90
- P/E Ratio
- SUPN $38.46
- LION N/A
- Revenue Growth
- SUPN 5.55
- LION 10.89
- 52 Week Low
- SUPN $29.16
- LION $5.55
- 52 Week High
- SUPN $46.79
- LION $8.50
- Technical
- Relative Strength Index (RSI)
- SUPN 58.01
- LION 61.53
- Support Level
- SUPN $43.44
- LION $7.06
- Resistance Level
- SUPN $46.72
- LION $7.69
- Average True Range (ATR)
- SUPN 1.08
- LION 0.31
- MACD
- SUPN -0.49
- LION 0.09
- Stochastic Oscillator
- SUPN 39.70
- LION 69.81
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.